These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22669751)

  • 21. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
    Yaqub A; Chung L
    Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020).
    Bălănescu P; Bălănescu A; Bălănescu E; Băicuş C
    Rom J Intern Med; 2021 Jun; 59(2):101-111. PubMed ID: 33565304
    [No Abstract]   [Full Text] [Related]  

  • 23. The heart and pulmonary arterial hypertension in systemic sclerosis.
    Vandecasteele EH; De Pauw M; Brusselle G; Decuman S; Piette Y; De Keyser F; Smith V
    Acta Clin Belg; 2016 Feb; 71(1):1-18. PubMed ID: 27075793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging biomarkers in systemic sclerosis.
    Manetti M
    Curr Opin Rheumatol; 2016 Nov; 28(6):606-12. PubMed ID: 27380110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
    Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M
    Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Gatzoulis MA; Settas L
    Semin Arthritis Rheum; 2010 Feb; 39(4):278-84. PubMed ID: 19539354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.
    Castelino FV; Varga J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very early diagnosis of systemic sclerosis.
    Bellando-Randone S; Guiducci S; Matucci-Cerinic M
    Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
    Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
    Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.
    Pattanaik D; Postlethwaite AE
    Discov Med; 2010 Aug; 10(51):161-7. PubMed ID: 20807477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS.
    Pawlik KK; Bohdziewicz A; Chrabąszcz M; Stochmal A; Sikora M; Alda-Malicka R; Czuwara J; Rudnicka L
    Wiad Lek; 2020; 73(10):2300-2305. PubMed ID: 33310967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers in systemic sclerosis.
    Castro SV; Jimenez SA
    Biomark Med; 2010 Feb; 4(1):133-47. PubMed ID: 20387310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations.
    Huang H; Fava A; Guhr T; Cimbro R; Rosen A; Boin F; Ellis H
    BMC Bioinformatics; 2015 Sep; 16():293. PubMed ID: 26373409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-16 expression is increased in the skin and sera of patients with systemic sclerosis.
    Kawabata K; Makino T; Makino K; Kajihara I; Fukushima S; Ihn H
    Rheumatology (Oxford); 2020 Mar; 59(3):519-523. PubMed ID: 31377804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.